project id: TCGA-BRCA; case submitter id: TCGA-V7-A7HQ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.18; rna integrity number: 7.6; age at index: 75; days to birth: -27684; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1934; age at diagnosis: 27684; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2033.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1493; initial weight: 50.0; oct embedded: false; preservation method: Unknown; sample id: 96c72a6b-a6c2-4965-be92-0910312689f3; sample submitter id: TCGA-V7-A7HQ-01A; portion id: 1813b745-a545-40d6-8894-12b07b7f0180; portion submitter id: TCGA-V7-A7HQ-01A-11; slide id: c4700f73-f50c-4e8c-8c2e-909a914a9413; slide submitter id: TCGA-V7-A7HQ-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 8.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;